Name: RXRX Balance Sheet - Recursion Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

RXRX - Recursion Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

RXRX Balance Sheet - Recursion Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Cash And Short Term Investments
Cash And Equivalents	743.3	594.4	391.6	549.9	285.1	262.1	-	-
Restricted Cash	4.6	3.0	3.2	1.3	1.6	2.0	-	-
Short Term Investments	-	-	-	0.0	231.4	0.0	-	-
Cash And Short Term Investments	743.3	594.4	391.6	549.9	516.6	262.1	-	-
Receivables
Accounts Receivable	-	-	-	0.0	0.0	0.2	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-
Prepaid Expenses	11.7	29.6	-	-	-	-
Non-Current Assets
Property, Plant & Equipment Gross	193.1	203.7	131.4	118.3	83.5	35.9	-	-
Accumulated Depreciation	89.2	62.7	44.9	30.1
Current Liabilities
Accounts Payable	18.1	21.6	4.0	4.6	2.8	1.1	-	-
Short Term Debt	-	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	0.7	-	-	-
Operating Lease Liabilities Non-Current	46.6	67.3	43.4	44.4	0.0
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	-	-
Additional Paid In Capital	3,170.1	2,473.7	1,431.1	1,125.4	943.1
Supplementary Data
Total Debt	-	-	-	-	0.7	-	-	-
Net debt	-	-	-	-	(515.8)	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q4 FY 18
Cash And Short Term Investments
Cash And Equivalents	654.5	743.3	659.8	525.1	500.5	594.4	427.6	474.3	296.3	391.6	387.3	405.9	473.1	-	454.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	11.7	11.7	0.0	0.0	2.5	29.6	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	24.2	28.6	29.2	37.3	32.0	38.1	42.7	43.7	41.5	40.2	17.8	18.8	15.6	-	13.2	17.0	15.4
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	709.6	812.8	714.1	587.2	584.1	714.3	474.2	522.4	343.6	438.1	410.5	431.0	492.1	-	481.6	546.0

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	140.9	136.1	135.6	131.4	127.1	127.4	123.6	-	112.8	105.6	92.1	83.5	71.7	62.3	56.0	35.9	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	56.5	52.4	48.9	44.9	40.8	37.6	33.6	-	27.1	24.1	21.4
Property,Plant & Equipment Net	95.8	103.9	111.7	120.0	126.8	141.1	84.4	83.6	86.7	86.5	86.2	89.8	90.0	-	85.8	81.5
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	160.2	162.2	162.0	164.3	158.1	148.9	52.1	52.1	52.1	52.1	52.8	60.5	0.8	-	0.8	0.8	0.8	0.8
Intangible Assets	294.1	309.9	322.3	341.3	335.8	335.9	34.1	38.2	33.1	36.4	39.5	42.8	1.3	-	1.5	1.2	1.3
Operating Lease Right Of Use Assets	42.8	45.3	47.8	50.3	53.2	65.9	47.9	44.1	35.5	33.7	34.1	34.9	35.1	32.9	33.7	34.6
Deferred Tax Assets	1.0	1.0	1.0	1.0	2.0	1.9	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	12.2	12.8	14.7	9.4	14.8	8.8	0.4	0.3	0.3	0.3	0.2	0.1	0.1	-	0.0	0.0	0.0
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	1,339.5	1,474.1	1,399.5	1,302.4	1,305.2	1,448.6	726.5	775.9	557.8	653.7	630.8	666.7	627.4	-	611.5	672.5	734.3

Current Liabilities
Accounts Payable	20.3	18.1	13.9	19.3	25.1	21.6	2.3	3.8	5.1	4.0	4.3	2.1	4.2	-	3.9	3.2	4.2	2.8	6.3	3.2	3.1	1.1	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	32.8	37.6	47.4	39.7	39.7	61.8	49.6	32.2	36.6	36.4	44.0	73.1	57.8	-	46.8	63.8	54.2
Operating Lease Liabilities Current	13.1	12.7	11.5	11.7	11.9	13.8	8.2	8.6	6.1	6.1	5.4	5.2	4.4	-	5.5	5.2
Accrued Expenses	54.2	70.2	53.1	64.3	56.8	81.9	40.6	33.4	26.1	46.6	39.8	32.9	25.0	-	26.8	24.4	23.1	32.3
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	129.7	147.7	155.1	164.0	142.0	187.5	108.9	86.1	73.9	93.2	94.1	114.0	92.2	-	83.0

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.7	12.7	12.7	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	42.8	46.6	50.0	53.4	56.0	67.3	53.7	50.2	43.8	43.4	44.3	45.9	46.8	-	46.0	47.8
Deferred Revenue Non-Current	114.7	114.0	111.2	126.2	129.6	118.8	15.7	29.2	37.4	51.2	51.4	32.4	57.1	-	93.9	89.9
Deferred Tax Liabilities	18.3	23.3	23.3	23.8	22.4	16.6	0.2	0.0	0.5	1.3	1.9	4.3	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	2.0	2.1	1.0	1.6	4.8	4.7	3.0	3.0	-	0.0	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	314.8	343.3	352.6	383.2	371.3	413.8	201.9	191.4	156.7	190.3	192.9	197.7	197.2	-	223.5	234.9

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-
Additional Paid In Capital	3,191.6	3,170.1	2,980.7	2,681.1	2,553.5	2,473.7	1,776.9	1,741.0	1,460.1	1,431.1	1,312.6	1,250.6	1,135.1	-	970.1	959.4
Retained Earnings	(2,193.5)	(2,076.0)	(1,967.9)	(1,805.6)	(1,633.7)	(1,431.3)	(1,252.4)	(1,156.5)	(1,059.0)	(967.6)	(874.6)	(781.6)	(704.9)	-	(582.1)	(521.6)	(456.1)
Accumulated Other Comprehensive Income	26.7	36.7	34.1	43.6	14.1	(7.6)	-	-	-	-	-	-	-	-	0.0	(0.2)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	1,024.8	1,130.9	1,046.9	919.1	933.9	1,034.8	524.6	584.4	401.2	463.4	438.0	469.0	430.2	-	388.0	437.6	493.6
Total Equity	1,024.8	1,130.9	1,046.9	919.1	933.9	1,034.8	524.6	584.4	401.2	463.4	438.0	469.0	430.2	-	388.0	437.6	493.6	542.9